A detailed history of Ddd Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ddd Partners, LLC holds 7,904 shares of PFE stock, worth $207,400. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,904
Holding current value
$207,400
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $218,940 - $248,106
7,904 New
7,904 $228,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $787 - $1,025
20 Added 0.38%
5,335 $217,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $2,379 - $3,106
-57 Reduced 1.06%
5,315 $272,000
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $3,938 - $4,807
-90 Reduced 1.65%
5,372 $235,000
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $6,839 - $8,109
147 Added 2.77%
5,462 $286,000
Q4 2021

Jan 24, 2022

BUY
$41.32 - $61.25 $219,615 - $325,543
5,315 New
5,315 $314,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ddd Partners, LLC Portfolio

Follow Ddd Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ddd Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ddd Partners, LLC with notifications on news.